


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
LCID
Lucid Group
$11.39
Risk Analysis

Earnings are forecast to decrease
LCID Price Performance
$10.9 (+4.50%)
$17.75 (-35.83%)
$16.16 (-29.52%)
$2.87 (+296.86%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Has a weak balance sheet

Below analyst estimate

Loss widens YoY

Revenue increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease
![]()
LCID Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LCID Street Sentiment is bullish but have mixed views on the near-term outlook
LCID has Fair risk level
Risks Indicators

Investors losing confidence

High volatilty

Average key support and resistance price levels
LCID
Lucid Group
11.39
+3.50%
EYE
National Vision Holdings
26.23
-0.64%
STLA
Stellantis N.V. Comm
9.81
+0.62%
ACB
Aurora Cannabis
4.39
-0.79%
WB
10.86
+0.18%
What is LCID current stock price?
What are LCID stock strengths?
What is LCID Risk Level?
What is LCID market cap and volume?
What is LCID current Stock IQ?
Should I buy LCID stock right now?
Is LCID a Strong Buy right now?
What does a 'Strong Buy' rating mean for LCID?
What does a 'Strong Sell' rating mean for LCID?
What factors influence LCID's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
LCID
Lucid Group
Current Price
$11.39
Stock Insights
Risk Analysis

Earnings are forecast to decrease
Recently Viewed
LCID
Lucid Group
11.39
+3.50%
EYE
National Vision Holdings
26.23
-0.64%
STLA
Stellantis N.V. Comm
9.81
+0.62%
ACB
Aurora Cannabis
4.39
-0.79%
WB
10.86
+0.18%

LCID Price Performance
$10.9 (+4.50%)
$17.75 (-35.83%)
$16.16 (-29.52%)
$2.87 (+296.86%)
LCID Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Has a weak balance sheet

Below analyst estimate

Loss widens YoY

Revenue increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease
![]()
LCID Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LCID Street Sentiment is bullish but have mixed views on the near-term outlook
LCID has Fair risk level
Risks Indicators

Investors losing confidence

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
NEUTRAL
Dec 22, 2025
Initiate
Buy
LUCID CAPITAL MARKETS
Dec 08, 2025
Upgrade
Buy
Morgan Stanley
Nov 18, 2025
Reiterate
Hold
Stifel
Nov 18, 2025
Initiate
Neutral
Lucid Capital
Nov 07, 2025
Reiterate
Neutral
Cantor Fitzgerald
LCID Stock IQ
LCID Latest Analysis
Why Did Lucid Stock Soar This Week?. Key PointsLucid has key support and financial backing of its largest shareholder.
Fri Jan 23, 2026
Heres Why Lucid Stock Jumped 22%—Saudi Support. LCID) shares surged nearly 18% on Wednesday and continued to climb on Thursday following news of reinforced backing from the Middle East.Despite being largely overlooked by the media a recent Cantor Fitzgerald report lifted Lucid shares after the EV maker hit a record low of $9.50 on Tuesday.LCID stock is climbing. See the chart and price action here.Cantor analysts met with representatives from the Saudi Public Investment Fund (PIF) to discuss the
Thu Jan 22, 2026
Lucid Group (LCID) Soars 20% on International Expansion. We recently published 10 Big Names Leaving Wall Street Behind. 7 Are Hitting Record Highs. Lucid Group Inc. (NASDAQ:LCID) was one of the worst performers on Wednesday. Lucid Group soared by as much as 19.6 percent on Wednesday to hit $11.64 at intra-day trading as investors took heart from its planned manufacturing expansion in Saudi [….]
Thu Jan 22, 2026
Tradr Rolls Out Short Leveraged ETFs on APLD IREN LCID & NBIS. Funds seek 200% inverse daily exposure on Applied Digital IREN Lucid and Nebius stock a provider of ETFs designed for sophisticated investors and professional traders today launched four new short leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver the inverse of twice (-200%) the daily performance of a specific underlying stock.The following ETFs are expected to open for trading today:Tradr 2X Short APLD Daily ET
Thu Jan 22, 2026
Why Lucid Stock Is Skyrocketing Today. Key PointsRockwell Automation announced today that it will be providing software for Lucids manufacturing plant in Saudi Arabia.
Wed Jan 21, 2026
LUCD PAVM Soar On United States Veterans Affairs Contract For EsoGuard DNA Test . (RTTNews) - Lucid Diagnostics Inc. (LUCD) a subsidiary of PAVmed Inc. (PAVM) announced that it has been awarded a contract by the United States Department of Veterans Affairs (VA) for its EsoGuard a DNA Test developed to detect oesophageal precancer.
Wed Jan 21, 2026
Why Is PAVmed Stock Skyrocketing Wednesday?. PAVM) stock rose Wednesday following the announcement that its subsidiaryLUCD) has been by the United States Department of Veterans Affairs (VA) for its EsoGuard Esophageal DNA Test.This news is contributing to the stock’.s impressive daily gain as broader markets are experiencing positive momentum with the Nasdaq up 0.70%.Lucid Diagnostics’. contract expands access to esophageal precancer testing across the VA’.s healthcare system whic
Wed Jan 21, 2026
Rockwell Powers Up Lucids Saudi Factory In A Big EV Push. On Wednesday ) said it had with LCID) to support the automaker’.s expanding manufacturing facility in Saudi Arabia.The plant located in King Abdullah Economic City (KAEC) represents a milestone as the Kingdom’.s first vehicle manufacturing site and aligns with Saudi Arabia’.s broader industrial development ambitions under Vision 2030.As part of the agreement Lucid will deploy Rockwell Automation’.s enterprise software
Wed Jan 21, 2026
Lucid Diagnostics Awarded United States Department of Veterans Affairs Contract for EsoGuard®. NEW YORK Jan. 21 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid or the Company) a commercial-stage cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM) today announced that it has been awarded a contract by the United States...
Wed Jan 21, 2026
Rockwell Automation partners with Lucid to support Saudi Arabia EV plant.
Wed Jan 21, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
LCID Stock trends
LCID Stock performance
LCID Stock analysis
LCID investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.